The new 3C technology allows for “tailored omega-3 EPA and DHA high concentrates,” according to DSM.
High-concentrate launches take top billing, but firms are also exploring other ways to differentiate their omega-3 offerings.
Can dietary supplements help manage the widespread effects of heightened inflammation?
Significantly higher blood levels of EPA omega-3s were found in study participants supplementing with Coromega products over other omega-3 emulsified liquids or soft gels.
Nutritional Outlook interviewed the Global Organization for EPA and DHA Omega-3s to find out if conditions have improved at all for omega-3 firms under FDA's new NDI draft guidance document.
The latest crop of omega-3 research nets positive data for depression, eye health, children’s health, and more.
Why we should take negative results from the AREDS2 study with a grain of salt for now.
Omega-3 ingredient innovations are bringing life back to a market still in recovery.
A new meta-analysis published by the U.S. Agency for Healthcare Research and Quality finds evidence that omega-3 consumption lowers triglycerides and raises HDL cholesterol, but its findings on other cardiovascular health markers are less strong.
Re-esterified omega-3 consumption was found to significantly improve tear osmolarity, tear beak-up time, and the ocular surface disease index in a new study.